Index by author
Baranowski, Brian
- You have accessManaging newly diagnosed atrial fibrillation: Rate, rhythm, and riskThomas Callahan, MD and Brian Baranowski, MDCleveland Clinic Journal of Medicine April 2011, 78 (4) 258-264; DOI: https://doi.org/10.3949/ccjm.78a.09165
Treatment focuses on controlling the heart rate, preventing thromboembolic events, and, depending on symptoms, restoring and maintaining sinus rhythm.
Bear, Joshua
- You have accessNausea, vomiting, and panic attacks in a 50-year-old womanJoshua Bear, MA and Franklin A. Michota, MDCleveland Clinic Journal of Medicine April 2011, 78 (4) 233-239; DOI: https://doi.org/10.3949/ccjm.78a.10082
Six months ago she started to have panic attacks that roused her from sleep. Lately, they have become more frequent and more severe. What is the cause?
Callahan, Thomas
- You have accessManaging newly diagnosed atrial fibrillation: Rate, rhythm, and riskThomas Callahan, MD and Brian Baranowski, MDCleveland Clinic Journal of Medicine April 2011, 78 (4) 258-264; DOI: https://doi.org/10.3949/ccjm.78a.09165
Treatment focuses on controlling the heart rate, preventing thromboembolic events, and, depending on symptoms, restoring and maintaining sinus rhythm.
Groen, David K.
- You have accessPharmacogenomic testing: Relevance in medical practiceJoseph P. Kitzmiller, MD, PhD, David K. Groen, MD, Mitch A. Phelps, PhD and Wolfgang Sadee, Dr rer natCleveland Clinic Journal of Medicine April 2011, 78 (4) 243-257; DOI: https://doi.org/10.3949/ccjm.78a.10145
Knowing their patients’ genetic status, physicians could predict their response to certain drugs, such as clopidogrel (Plavix), warfarin (Coumadin), tamoxifen (Nolvadex), codeine, and psychotropic medications.
Kitzmiller, Joseph P.
- You have accessPharmacogenomic testing: Relevance in medical practiceJoseph P. Kitzmiller, MD, PhD, David K. Groen, MD, Mitch A. Phelps, PhD and Wolfgang Sadee, Dr rer natCleveland Clinic Journal of Medicine April 2011, 78 (4) 243-257; DOI: https://doi.org/10.3949/ccjm.78a.10145
Knowing their patients’ genetic status, physicians could predict their response to certain drugs, such as clopidogrel (Plavix), warfarin (Coumadin), tamoxifen (Nolvadex), codeine, and psychotropic medications.
Makadon, Harvey J.
- You have accessEnding LGBT invisibility in health care: The first step in ensuring equitable careHarvey J. Makadon, MDCleveland Clinic Journal of Medicine April 2011, 78 (4) 220-224; DOI: https://doi.org/10.3949/ccjm.78gr.10006
Lesbian, gay, bisexual, and transgender individuals experience health care disparities that will be eliminated only if clinicians elicit information in a thoughtful, nonjudgmental way.
Makrygeorgou, Areti
- You have accessLeukemia cutisChristos Tziotzios, BA, MA, MB, BChir (Cantab) and Areti Makrygeorgou, MDCleveland Clinic Journal of Medicine April 2011, 78 (4) 226-227; DOI: https://doi.org/10.3949/ccjm.78a.10127
This condition occurs in 10% to 15% of patients with acute myeloid leukemia and is a poor prognostic sign.
Mandell, Brian F.
- You have accessGene-based, rational drug-dosing: An evolving, complex opportunityBrian F. Mandell, MD, PhDCleveland Clinic Journal of Medicine April 2011, 78 (4) 218; DOI: https://doi.org/10.3949/ccjm.78b.11004
Pharmacogenomics promises the opportunity to match the right drug and dose to the right patient. We are not there yet, but the day is coming.
Michota, Franklin A.
- You have accessNausea, vomiting, and panic attacks in a 50-year-old womanJoshua Bear, MA and Franklin A. Michota, MDCleveland Clinic Journal of Medicine April 2011, 78 (4) 233-239; DOI: https://doi.org/10.3949/ccjm.78a.10082
Six months ago she started to have panic attacks that roused her from sleep. Lately, they have become more frequent and more severe. What is the cause?
Phelps, Mitch A.
- You have accessPharmacogenomic testing: Relevance in medical practiceJoseph P. Kitzmiller, MD, PhD, David K. Groen, MD, Mitch A. Phelps, PhD and Wolfgang Sadee, Dr rer natCleveland Clinic Journal of Medicine April 2011, 78 (4) 243-257; DOI: https://doi.org/10.3949/ccjm.78a.10145
Knowing their patients’ genetic status, physicians could predict their response to certain drugs, such as clopidogrel (Plavix), warfarin (Coumadin), tamoxifen (Nolvadex), codeine, and psychotropic medications.